These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 32171323)

  • 1. Efficacy and safety of Shu-gan-qing-re formula for generalized anxiety disorder: study protocol for a multi-center, prospective, double-blind, double-dummy, randomized controlled trial.
    Chen P; Zhu H; Ning Y; Yin D; Jia H
    Trials; 2020 Mar; 21(1):266. PubMed ID: 32171323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chinese herbal medicine bi min fang for allergic rhinitis: protocol for a double-blind, double-dummy, randomized controlled trial.
    Luo Q; Zhou S; Li X; Chen Q; Lin W; Lu L; Li H; Chen C; Chen W; Li Y
    Trials; 2019 Jan; 20(1):66. PubMed ID: 30658660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial.
    Sha Z; Hou Y; Xue C; Li O; Li Z; Wang H; Zhang W; Xu J
    Trials; 2020 Jan; 21(1):107. PubMed ID: 31973702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative clinical study of efficacy of Gamisoyo-San (Jiaweixiaoyaosan) on generalized anxiety disorder according to differently manufactured preparations: multicenter, randomized, double blind, placebo controlled trial.
    Park DM; Kim SH; Park YC; Kang WC; Lee SR; Jung IC
    J Ethnopharmacol; 2014 Dec; 158 Pt A():11-7. PubMed ID: 25456420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Jie Yu Wan on Generalized Anxiety Disorder: A Randomized Clinical Trial.
    Li X; Zheng S; Feng S; Ma R; Jia Y; Zhao A; Wei D; Guo H; Duan N; Ding Y; Chen J; Zhu H; Jia H
    Evid Based Complement Alternat Med; 2022; 2022():9951693. PubMed ID: 35432560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD).
    Cutler NR; Sramek JJ; Macpherson AE; Doss MG; Benes CO; Howard SF
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):685-94. PubMed ID: 7938559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
    Davidson JR; DuPont RL; Hedges D; Haskins JT
    J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of Lian-Ju-Gan-Mao capsules for treating the common cold with wind-heat syndrome: study protocol for a randomized controlled trial.
    Wang S; Jiang H; Yu Q; She B; Mao B
    Trials; 2017 Jan; 18(1):2. PubMed ID: 28057058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial.
    Shen Z; Zheng K; Zou J; Gu P; Xing J; Zhang L; Zhu L; Shen H
    Trials; 2021 Jan; 22(1):55. PubMed ID: 33441157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of Shugan granule in the treatment of mixed anxiety-depressive disorder: A multicenter, randomized, double-blind, placebo-controlled trial.
    Li Y; Li L; Guo R; Yu H; Wang X; Wang B; Wang Q; Li Z; Zhao H; Temu Q; Chen X; Zhang Y; An J; Cai X; Li A; Qi L; Shang J; He H; Yang D; Lin J; Zhang Y; Zou T
    J Ethnopharmacol; 2022 May; 290():115032. PubMed ID: 35085742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder.
    Amsterdam JD; Li Y; Soeller I; Rockwell K; Mao JJ; Shults J
    J Clin Psychopharmacol; 2009 Aug; 29(4):378-82. PubMed ID: 19593179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study.
    Llorca PM; Spadone C; Sol O; Danniau A; Bougerol T; Corruble E; Faruch M; Macher JP; Sermet E; Servant D
    J Clin Psychiatry; 2002 Nov; 63(11):1020-7. PubMed ID: 12444816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of Qing-Feng-Gan-Ke Granules in patients with postinfectious cough: study protocol of a novel-design phase III placebo-controlled, double-blind randomized trial.
    Liu W; Jiang H; Zhang R; Jin F; Liu L; Long Y; Cui L; Li S; Zhong Y; Mao B
    BMC Complement Altern Med; 2015 Aug; 15():290. PubMed ID: 26286147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sang-qi granules on blood pressure and endothelial dysfunction in stage I or II hypertension: study protocol for a randomized double-blind double-simulation controlled trial.
    Shi H; Yang D; Qiao J; Sun R; Li R; Zhu C; Jing R; Liu L; Huang L; Li L
    Trials; 2020 Jan; 21(1):12. PubMed ID: 31907056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of replenishing and regulating for manic episode in bipolar disorder: study protocol for a prospective, double-blind, randomized controlled trial.
    Yang Y; Haining Y; Hongxiao J; Yanzhe N; Di W; Lei Z; Kaijuan Y; Yumeng G; Fei W; Weishuang S; Pei C
    J Tradit Chin Med; 2023 Jun; 43(3):594-601. PubMed ID: 37147763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.